Clinical Trial Update: An Efficacy And Safety Study of CNTO 6785 In Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy [Phase 2]

View source ↗

Summary

This Phase 2 trial update evaluates the efficacy and safety of CNTO 6785 in participants with active rheumatoid arthritis despite methotrexate therapy, and the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CNTO 6785

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED